WCG Unveils Results from 2023 Global Site Relationship Benchmark Survey Report
Princeton, NJ – May 24, 2023 – WCG, one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, released key results from the 2023 CenterWatch Global Site Relationship Benchmark Survey Report. The results show how more than 3,600 representatives from clinical trial sites around the world rate their […]
WCG Releases 2023 Report on Top Issues Impacting Clinical Research Sites
Princeton, NJ – May 18, 2023 – WCG, one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, today released the WCG 2023 Clinical Research Site Challenges Survey Report. The report features the latest data and insights from clinical research sites about the most significant challenges impacting […]
WCG Launches 360 Protocol Assessment™ Solution to Ensure Protocol Quality by Design
Princeton, N.J. – May 9, 2023 – WCG, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today launched 360 Protocol Assessment™, an integrated, turn-key solution that addresses ICH E8 R1 expectations and improves clinical trial predictability by providing sponsors with an operational risk and feasibility assessment of the […]
WCG Clinical Announces Relaunch of FDAnews as the Premier Source for Drug and Device Insights
Princeton, NJ, April 3, 2023: WCG Clinical announces the relaunch of its publication FDAnews, a trusted resource for pharmaceutical and medical device insights for more than 50 years. The relaunch will combine the products Drug Industry Daily, Device Daily Bulletin Premium, Drug Daily Bulletin and Device Daily Bulletin into one content destination at FDAnews.com. In […]
WCG Collaborates With Leading Multiple Sclerosis KOL to Launch Neurostatus-eEDSS System
Princeton, N.J. – February 23, 2023 – WCG, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today launched a new Neurostatus-eEDSS system. WCG collaborated with Neurostatus-UHB Ltd., a University Hospital Basel (UHB) subsidiary led by CEO Marcus D’Souza, M.D. and Chief Operating Officer Evy Fricker, to develop […]
WCG Releases Clinical Research Trends & Insights for 2023
Princeton, N.J. – January 9, 2023 – WCG, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today released its Clinical Research Trends & Insights for 2023 report. In this 2023 preview, 14 thought leaders from WCG share the important shifts, trends, regulations, and priorities they believe will […]
WCG’s New Seizure eDiary Optimizes Data Collection and Simplifies the Participant Experience
Princeton, NJ – November 29, 2022 – WCG, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today launched a new Electronic Seizure Diary (eDiary), which is used to help patients with seizure disorders and their caregivers self-monitor and manage their seizures. WCG is one of two providers […]
WCG Introduces First-of-its-Kind Safety Reference Model for Safety Reporting
Princeton, NJ – October 4, 2022 – WCG, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, published the Safety Reference Model. A first-of-its-kind operational guide for handling safety reporting to investigators, ethics committees, and competent authorities, the Safety Reference Model (SRM) was developed in response to the […]
WCG IRB Expands Phase I Review Services, Partners With Dr. Vince Clinical Research
PRINCETON, N.J. & OVERLAND PARK, Kan. — WCG, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the expansion of its Phase I review services, providing purpose-built operations for Phase I investigators. Launched in conjunction with the opening of Dr. Vince Clinical Research’s (DVCR) industry-leading, green-designed […]
WCG’s Lori Abrams Honored as a PharmaVoice 100 Diversity, Equity, and Inclusion Champion
Princeton, NJ, September 6, 2022 – WCG, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that Lori Abrams, Vice President, Patient Advocacy and Clinical Research Diversity, has been named a Diversity, Equity, and Inclusion Champion in the PharmaVoice 100 Class of 2022. “Lori has been […]